JACQUELINE DEFFENBAUGH: Open Payments
NPI 1174535306 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 36 payments from 8 companies in 2025. Trend: 2023 $454 · 2024 $561 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $272 |
| Exact Sciences Corporation | 4 | $86 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $81 |
| Organon LLC | 3 | $68 |
| Astellas Pharma US Inc | 3 | $65 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $47 |
| Novo Nordisk Inc | 2 | $45 |
| Biogen, Inc. | 2 | $43 |
Products named: GEMTESA, NEXPLANON, Cologuard Collection Kit, Veozah, MYFEMBREE, JOURNAVX, Wegovy, ZURZUVAE.
Industry payments across IL — which companies pay providers there.
